Kvetiapin Accord (Quetiapine)

Quetiapine works by blocking serotonin 5‑HT2A and dopamine D2 receptors, which reduces psychotic and mood‑disrupting signals. It also blocks histamine H1 and adrenergic α1 receptors, and partially stimulates 5‑HT1A receptors, contributing to its calming and antidepressant effects.

The appropriate dose of Kvetiapin Accord is individualized by the prescribing clinician based on the patient’s diagnosis, severity of symptoms, prior treatment response, and tolerability. No fixed regimen is provided here; the prescriber sets the dosage and titration schedule.

Quetiapine should be used during pregnancy or lactation only when the potential therapeutic benefit outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case carefully and discuss potential concerns with obstetric or pediatric specialists.

To order Kvetiapin Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with other atypical antipsychotics, quetiapine has a relatively lower affinity for dopamine D2 receptors and a higher affinity for histamine H1, which often results in pronounced sedation and weight gain. Its broader receptor profile can be advantageous for treating both psychosis and mood symptoms, but side‑effect profiles differ among agents.

Kvetiapin Accord should be stored at ambient temperature below 25 °C, protected from moisture and direct light. Keep the tablets in the original packaging until use to maintain stability and potency.

Kvetiapin Accord is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include neuroleptic malignant syndrome, tardive dyskinesia, severe hypotension, agranulocytosis, and the emergence of suicidal thoughts, especially early in treatment. Patients should be monitored closely for any sudden changes in mood, movement disorders, or signs of infection.

Kvetiapin Accord is contraindicated in individuals with known hypersensitivity to quetiapine or any of its excipients. Caution is advised for patients with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare professional.